Cheryl Schneider

• 
  www.investorrelationsgroup.com/management.html - [Cached Version]
  Published on: 2/26/2008    Last Visited: 2/26/2008  

  Cheryl Schneider, Executive Vice President has more than 20 years' experience in investor relations.Prior to joining IRG, Cheryl was Executive Director and Vice President of Porter, LeVay & Rose, an investor relations/corporate communications consultancy, Senior Vice President of Broadgate Consultants, a capital markets positioning firm, and was Principal and Group Director at Morgen-Walke Associates, where she implemented investor relations programs for emerging growth companies.She was also the Managing Director of the American Stock Exchange, where she was responsible for developing the investor relations division, providing investment community outreach programs for listed companies.Cheryl served as Vice President and Corporate Secretary, and was a member of the Board of Directors of the National Investor Relations Institute's New York Chapter, for six years.She has an MBA in Marketing and International Business from New York University's Stern School of Business and a BA in French from the State University of New York at Binghamton.

• 
  phx.corporate-ir.net/phoenix.zhtml?c=80677&p=irol-newsA - [Cached Version]
  Published on: 4/3/2006    Last Visited: 7/26/2008  

  Cheryl Schneider, VP - Investor Relations

• 
  9/07/04 - [Cached Version]
  Published on: 9/7/2004    Last Visited: 9/14/2004  

  Cheryl Schneider, VP - Investor Relations

• 
  Biospace.com - [Cached Version]
  Published on: 2/6/2006    Last Visited: 2/7/2006  

  CONTACT: Paul E. Freiman, President & CEO of Neurobiological Technologies,Inc., +1-510-595-6000; or Cheryl Schneider, VP - Investor Relations ofPorter, Le Vay & Rose, Inc., +1-212-564-4700, for NeurobiologicalTechnologies, Inc.

• 
  Fuel Tech - technology for a renewed environment - [Cached Version]
  Published on: 4/27/1999    Last Visited: 11/24/2001  

  Cheryl Schneider 380 Lexington Ave., 51st Flr New York, NY 10168-5199 Telephone: (212) 850-5600 Facsimile: (212) 850-5790

• 
  Jack O'Dwyer's Newsletter - [Cached Version]
  Published on: 10/11/2008    Last Visited: 8/26/2002  

  Cheryl Schneider, principal and group director of Morgen-Walke Assocs., New York, has left the company.She joined several years ago from the American Stock Exchange, where she was managing director responsible for IR programs.
  
  BIN LADEN FAMILY TAPS HULLIN METZ
  
  Saudi Arabia's Bin Laden family is using Hullin Metz & Co. to make sure reporters know that it signed a statement officially disowning Osama bin Laden in 1994, a year following the first terror attack on the World Trade Center.

• 
  Neurobiological Technologies, Inc. (NTII) Receives FDA... - [Cached Version]
  Published on: 5/22/2004    Last Visited: 1/30/2005  

  CONTACT: Paul E. Freiman, President & CEO of NeurobiologicalTechnologies, Inc., +1-510-262-1730; or Cheryl Schneider, VP, InvestorRelations, or Jeff Myhre, VP, Editorial, both of Porter, Le Vay & Rose, Inc.,+1-212-564-4700, for Neurobiological Technologies, Inc.

• 
  PBS Holding, Inc. - Investor Relations - News Release - [Cached Version]
  Published on: 2/8/2006    Last Visited: 4/23/2007  

  Cheryl Schneider, VP - Investor Relations

• 
  SYS Technologies Announces Contract Awards with U.S.... - [Cached Version]
  Published on: 8/2/2005    Last Visited: 8/2/2005  

  Cheryl Schneider, VP, Investor Relations Jeff Myhre, VP, Editorial 212-564-4700 Tom Gibson, Media Relations 201-476-0322

• 
  StockHouse USA -- News -- - [Cached Version]
  Published on: 10/11/2008    Last Visited: 11/2/2004  

  Paul E. Freiman, President & CEO of Neurobiological Technologies, Inc., +1-510-262-1730; or Cheryl Schneider, VP, Investor Relations of Porter, Le Vay & Rose, Inc., +1-212-564-4700, for Neurobiological Technologies, Inc. http://www.ntii.com

Page:  1 2